United Kingdom · Investor

Tate & Lyle Ventures

Last cheque observed Apr 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietVC firm

VentureSeries BSeries A

Cheques on record
0%of best year0cheques in 12 months, 8 on record
Since the last cheque3476days00hrs00min00sec
Median round$8.0MRounds led0 of 8Sole investor1 roundsExits1 from the portfolioMostly inUnited States, 50%
Pitch Tate & Lyle Ventures

Tate & Lyle Ventures highlights

  1. 01

    8 rounds on record

  2. 02

    Mostly Venture and Series B: 71% of its rounds

  3. 03

    Sole investor in 1 rounds, median undisclosed

  4. 04

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Based in
London, United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2017

    1 round

  2. Apr
    NutriatiUS · Foodingredientsfirst$8.0MWith 3 others
  3. 2015

    1 round

  4. Aug
    Evolve BiosystemsSeries A · US$9.0MWith 1 other
  5. 2012

    1 round

  6. Mar
    AllylixVenture · US · finsmes.com$18MWith 3 others
  7. 2011

    1 round

  8. May
    LumoraSeries B · GB · finsmes.com$2.4MWith 1 other
  9. 2010

    1 round

  10. Apr
    Aquapharm BiodiscoverySeries C · GB · coursework.stanford.edu$6.4MWith 3 others
  11. 2007

    3 rounds

  12. Nov
    AllylixVenture · US$3.4MWith 4 others
  13. Jul
    Aquapharm BiodiscoverySeries B · GB · talentscotland.com$8.2MWith 4 others
  14. Jan
    LumoraVenture · GBUndisclosedSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

AllylixBought by EvolvaUndisclosedNov 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Tate & Lyle Ventures. A count of rooms they were both in, not a relationship either has claimed.

AescapGovernment2rounds togetherNestaVC firm2rounds together

Recently backed

The latest companies Tate & Lyle Ventures put money into.

Nutriati$8.0M · Apr 2017

Quick answers about Tate & Lyle Ventures

What does Tate & Lyle Ventures invest in?

Tate & Lyle Ventures invests most often at Venture and Series B (71% of the rounds on record).

How active is Tate & Lyle Ventures?

8 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2017.

What has Tate & Lyle Ventures invested in recently?

Its most recent investments on record: Nutriati (Undisclosed round, Apr 2017).

How big are Tate & Lyle Ventures's cheques?

The median round it joins is $8.0M.

Does Tate & Lyle Ventures lead rounds?

Rarely, if at all: none of its 8 investments on record names it as the lead.

Where does Tate & Lyle Ventures invest?

Most of the companies it backs are in the United States (50%) and the United Kingdom (50%).

Is Tate & Lyle Ventures investing now?

No investments in the last 12 months; the latest was in Apr 2017.

Who does Tate & Lyle Ventures invest alongside?

Most often Aescap (2 rounds together) and Nesta (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it